{"id":"https://openalex.org/W3083030145","doi":"https://doi.org/10.1158/1538-7445.am2020-800","title":"Abstract 800: Exploiting the proteasome to overcome RAS and WT1 mutation mediated resistance to FLT-3 inhibition in acute myeloid leukemia","display_name":"Abstract 800: Exploiting the proteasome to overcome RAS and WT1 mutation mediated resistance to FLT-3 inhibition in acute myeloid leukemia","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3083030145","doi":"https://doi.org/10.1158/1538-7445.am2020-800","mag":"3083030145"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-800","doi":"https://doi.org/10.1158/1538-7445.am2020-800","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-800","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068087379","display_name":"Sravanti Rangaraju","orcid":"https://orcid.org/0000-0003-3545-0661","observed_orcids":["https://orcid.org/0000-0003-3545-0661"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sravanti Rangaraju","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018541250","display_name":"Santhosh Kumar Pasupuleti","orcid":"https://orcid.org/0000-0001-5770-7187","observed_orcids":["https://orcid.org/0000-0001-5770-7187"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh Kumar Pasupuleti","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102790491","display_name":"Silvia Marino","orcid":"https://orcid.org/0000-0003-3695-0908","observed_orcids":["https://orcid.org/0000-0003-3695-0908","https://orcid.org/0000-0002-9612-2883","https://orcid.org/0000-0002-1088-6808"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Silvia Marino","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053280068","display_name":"Daniela Nicoleta Petrusca","orcid":"https://orcid.org/0000-0002-6782-2995","observed_orcids":["https://orcid.org/0000-0002-6782-2995"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela Nicoleta Petrusca","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016061346","display_name":"Larry Dean Cripe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry D. Cripe","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006106475","display_name":"Bhaskar Ramdas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhaskar Ramdas","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088156146","display_name":"Lakshmi Reddy Palam","orcid":"https://orcid.org/0000-0002-9516-6278","observed_orcids":["https://orcid.org/0000-0002-9516-6278"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi Reddy Palam","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019460986","display_name":"Katie J. Sargent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie J. Sargent","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047713667","display_name":"Hamid Sayar","orcid":"https://orcid.org/0000-0002-1047-8783","observed_orcids":["https://orcid.org/0000-0002-1047-8783"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hamid Sayar","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025627179","display_name":"Heiko Koenig","orcid":"https://orcid.org/0000-0002-6871-7388","observed_orcids":["https://orcid.org/0000-0002-6871-7388"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heiko Konig","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035841414","display_name":"Reuben Kapur","orcid":"https://orcid.org/0000-0003-2225-1700","observed_orcids":["https://orcid.org/0000-0003-2225-1700","https://orcid.org/0009-0008-1025-5126"]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reuben Kapur","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007296257","display_name":"David Roodman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David G. Roodman","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011409960","display_name":"Scott H. Boswell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott H. Boswell","raw_affiliation_strings":["Indiana University, Indianapolis, IN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN","institution_ids":["https://openalex.org/I4388446366"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4388446366"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"800","last_page":"800"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/flt3-mutation","display_name":"FLT3 mutation","score":0.8370000123977661},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.9229999780654907},{"id":"https://openalex.org/keywords/wt1-mutations","display_name":"WT1 mutations","score":0.8629999756813049},{"id":"https://openalex.org/keywords/ixazomib","display_name":"ixazomib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9620000123977661},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7129999995231628},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9710000157356262},{"id":"https://openalex.org/keywords/co-mutations","display_name":"co-occurring mutations","score":0.5329999923706055},{"id":"https://openalex.org/keywords/dnmt3a","display_name":"DNMT3A","score":0.871999979019165},{"id":"https://openalex.org/keywords/npm1","display_name":"NPM1","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.46299999952316284},{"id":"https://openalex.org/keywords/patient-derived-cells","display_name":"patient-derived cells","score":0.4959999918937683},{"id":"https://openalex.org/keywords/mv4-11","display_name":"MV4-11","score":0.6840000152587891},{"id":"https://openalex.org/keywords/thp-1-cells","display_name":"THP-1 cells","score":0.9850000143051147}],"concepts":[{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7076787948608398},{"id":"https://openalex.org/C2781098529","wikidata":"https://www.wikidata.org/wiki/Q20948663","display_name":"Ixazomib","level":5,"score":0.6834062337875366},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6105496287345886},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.5247880816459656},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.46696239709854126},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46233460307121277},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.4545750319957733},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4329954981803894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3947729766368866},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.390459269285202},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3629169464111328},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34866225719451904},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2722548246383667},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.14201292395591736},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.11829066276550293},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.10956138372421265},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09916162490844727},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07290086150169373}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-800","doi":"https://doi.org/10.1158/1538-7445.am2020-800","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-800","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2749281617","https://openalex.org/W1529564611","https://openalex.org/W2431218506","https://openalex.org/W4409208323","https://openalex.org/W2968747963","https://openalex.org/W2979594966","https://openalex.org/W4415596405","https://openalex.org/W2988524895","https://openalex.org/W4385767046","https://openalex.org/W2620653306"],"abstract_inverted_index":{"Abstract":[0],"FLT3":[1,29,268,477],"mutations":[2,18,36,177,244,265],"(mFLT3)":[3],"in":[4,116,124,210,217,258,282,325,390,406,436,448,468,552],"acute":[5,553],"myeloid":[6,554],"leukemia":[7,555],"(AML)":[8],"carry":[9],"a":[10,64,200,333,347,374,449,459],"poor":[11],"prognosis.The":[12],"mandatory":[13],"co-occurrence":[14,239],"of":[15,40,51,68,83,134,143,155,161,164,169,202,240,263,267,304,332,365,376,488,496,559,563],"other":[16],"driver":[17],"with":[19,26,74,110,118,152,167,215,368,480],"mFLT3":[20,84],"leads":[21],"to":[22,45,54,79,97,225,234,248,254,273,280,290,295,312,329,345,403,451,462,465,485,500,541,549],"suboptimal":[23],"clinical":[24],"responses":[25],"single":[27,46],"agent":[28,47,157,166],"inhibitors":[30],"(FLT3i).":[31],"Pre-existing":[32],"or":[33,87,103,123,220,242,393,470,490],"emergent":[34],"RAS":[35,86,241,264,313,392,437,469,543],"are":[37,93,483],"one":[38,165],"mechanism":[39],"primary":[41,203,391],"and":[42,85,99,114,120,137,159,193,257,284,340,385,410,428,453,475,493,544,574],"secondary":[43],"resistance":[44,56,247,548],"FLT3i.":[48],"Therefore":[49],"development":[50],"combinatorial":[52],"strategies":[53],"overcome":[55,501,542],"conferring":[57],"co-mutations":[58,216,482],"is":[59,310,327,498],"critical.":[60],"Herein":[61],"we":[62,398,457],"report":[63],"novel":[65],"in-vitro":[66],"combination":[67,160],"the":[69,170,386,494,539,560,564],"FLT3/SYK":[70],"inhibitor":[71,76],"(FSI)":[72],"TAK-659":[73,119,226,249,291],"Proteasome":[75],"(PI)":[77],"ixazomib,":[78],"co-operatively":[80],"inhibit":[81],"proliferation":[82,147],"WT1":[88,243,323,394,471,545],"co-mutated":[89],"AML":[90,111,204,315,326,396,473,479],"blasts,":[91],"which":[92],"otherwise":[94],"less":[95,232],"sensitive":[96,224,233,289],"Flt3i":[98],"FSI.":[100],"Peripheral":[101],"blood":[102],"bone":[104],"marrow":[105],"derived":[106],"cells":[107,253],"from":[108],"patients":[109],"were":[112,129,149,174,184,222,433],"isolated":[113],"treated":[115],"vitro":[117],"Ixazomib":[121,235,281,296],"alone":[122,236,256,492],"combination.":[125,259],"Cytosolic/nuclear":[126],"protein":[127],"lysates":[128],"obtained":[130],"at":[131],"12":[132],"hours":[133],"drug/control":[135],"treatment":[136,401],"western":[138],"blotting":[139],"performed":[140,151],"for":[141,176,246,271,337,567],"proteins":[142],"interest.":[144],"Tritiated":[145],"thymidine":[146],"assays":[148,198],"also":[150,277,381,434,444],"titrated":[153],"doses":[154],"each":[156],"alone,":[158],"fixed":[162],"dose":[163],"titration":[168],"second.":[171],"Patient":[172],"samples":[173,205,214],"annotated":[175],"by":[178,308,383],"Next":[179],"Generation":[180],"Sequencing.":[181],"Similar":[182,431],"experiments":[183,443],"carried":[185],"out":[186],"on":[187,199,299],"cell":[188,379,439],"lines":[189],"MV411":[190],"(Flt3ITD/MLL),":[191],"THP-1":[192,283],"OCI-AML3":[194],"(both":[195],"NRAS).":[196],"Proliferation":[197],"series":[201],"revealed":[206],"an":[207],"inherent":[208],"dichotomy":[209],"response":[211],"patterns.":[212],"mFLT-3":[213],"DNMT3A,":[218],"NPM1":[219],"tMLL":[221],"very":[223],"(IC50":[227],"<75":[228],"nM)":[229],"but":[230,250,292],"much":[231],"(IC50>100nM).":[237],"The":[238],"predicted":[245,270],"interestingly":[251],"sensitized":[252],"PI":[255,274,361,400,424,497],"In":[260,455],"fact,":[261],"presence":[262],"irrespective":[266],"status":[269],"sensitivity":[272,279],"(IC50<50nM).":[275],"We":[276,357],"observed":[278,399],"OCI-AML3,":[285],"while":[286],"MV4-11":[287],"was":[288],"relatively":[293],"resistant":[294],"alone.":[297],"Based":[298],"genome-wide":[300],"CRISPR":[301],"screen,":[302],"overactivity":[303],"RAC-PAK":[305],"signaling":[306],"mediated":[307,547],"PREX1":[309],"essential":[311],"mutated":[314,395,472,478],"(T":[316],"Wang":[317,350],"etal.":[318],"Cell":[319],"168:890,":[320],"2017).":[321],"Similarly,":[322],"mutation":[324,546],"known":[328],"ablate":[330],"expression":[331],"major":[334],"nuclear":[335,363,407,412],"chaperone":[336,370],"beta-catenin,":[338],"TBL1X,":[339],"RAC":[341],"has":[342],"been":[343],"found":[344],"be":[346,463],"substitute":[348],"(Y":[349],"et":[351],"al.":[352],"Mol":[353],"Cell.":[354],"57:662,":[355],"2015).":[356],"therefore":[358],"hypothesized":[359],"that":[360],"decreased":[362,411],"availability":[364],"RAC1":[366,408],"along":[367],"its":[369],"partner":[371],"beta-catenin":[372,413,429],"-":[373],"determinant":[375],"leukemic":[377],"stem":[378],"activity,":[380],"regulated":[382],"RAC/PAK":[384],"proteasomal":[387],"system.":[388],"Indeed,":[389],"samples,":[397],"led":[402],"significant":[404],"reduction":[405],"levels":[409],"levels,":[414],"specifically":[415],"PAK":[416,427],"phosphorylated":[417],"p675":[418],"active":[419],"beta-catenin.":[420,454],"These":[421],"findings":[422],"suggest":[423],"effects":[425],"RAC1,":[426],"simultaneously.":[430],"results":[432],"noted":[435],"mutant":[438],"lines.":[440],"siRNA":[441],"knockdown":[442],"linked":[445,464],"p62":[446],"SQSTM1":[447],"pathway":[450,461],"RAS/RAC/PAK":[452],"summary,":[456],"delineate":[458],"RAS/RAC/PAK/Beta-catenin":[460],"critical":[466,499],"events":[467],"progression":[474],"resistance.":[476],"these":[481],"insensitive":[484],"single-agent":[486],"activity":[487],"FLT3i":[489],"FSI":[491],"addition":[495],"them.":[502],"Citation":[503],"Format:":[504],"Sravanti":[505],"Rangaraju,":[506],"Santosh":[507],"Kumar":[508],"Pasupuleti,":[509],"Silvia":[510],"Marino,":[511],"Daniela":[512],"Nicoleta":[513],"Petrusca,":[514],"Larry":[515],"D.":[516],"Cripe,":[517],"Bhaskar":[518],"Ramdas,":[519],"Lakshmi":[520],"Reddy":[521],"Palam,":[522],"Katie":[523],"J.":[524],"Sargent,":[525],"Hamid":[526],"Sayar,":[527],"Heiko":[528],"Konig,":[529],"Reuben":[530],"Kapur,":[531],"David":[532],"G.":[533],"Roodman,":[534],"Scott":[535],"H.":[536],"Boswell.":[537],"Exploiting":[538],"proteasome":[540],"FLT-3":[550],"inhibition":[551],"[abstract].":[556],"In:":[557],"Proceedings":[558],"Annual":[561],"Meeting":[562],"American":[565],"Association":[566],"Cancer":[568,580],"Research":[569],"2020;":[570],"2020":[571],"Apr":[572],"27-28":[573],"Jun":[575],"22-24.":[576],"Philadelphia":[577],"(PA):":[578],"AACR;":[579],"Res":[581],"2020;80(16":[582],"Suppl):Abstract":[583],"nr":[584],"800.":[585]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2020-09-11T00:00:00"}